Halozyme Therapeutics
HALOHalozyme Therapeutics is a U.S. biotechnology company that develops novel oncology therapies designed to target the tumor microenvironment and licenses a novel drug delivery technology through corporate partnerships. The company was founded in 1998 and went public in 2004. Halozyme is headquartered …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at Halozyme Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 4/6/2026 | Sell | Torley, Helen | PRESIDENT AND CEO | $63.6 | $634,982 |
| 4/2/2026 | Sell | Torley, Helen | PRESIDENT AND CEO | $64.5 | $1,284,720 |
| 4/1/2026 | Sell | Torley, Helen | PRESIDENT AND CEO | $65.5 | $1,307,516 |
| 3/10/2026 | Sell | Caudill, Cortney | SVP, CHIEF OPERATING OFFICER | $67.6 | $599,087 |
| 3/9/2026 | Sell | Caudill, Cortney | SVP, CHIEF OPERATING OFFICER | $68.0 | $1,356,072 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)